Literature DB >> 6262560

Effects of myeloproliferative sarcoma virus on the pluripotential stem cell and granulocyte precursor cell populations of DBA/2 mice.

B Klein, C Le Bousse, B Fagg, F Smajda-Joffe, K Vehmeyer, K J Mori, C Jasmin, W Ostertag.   

Abstract

The hematopoietic stem cell (CFU-S) and granulocyte precursor cell (CFU-C) populations have been assayed in the spleen, blood, and bone marrow of DBA/2 mice at various times after infection with the myeloproliferative sarcoma virus (MPSV). Beginning between 7 and 19 days after virus infection, the number of CFU-S showed a steady, parallel increase in the blood and spleen, reaching a maximum at both sites by days 25-30. At the maximum, in the spleen the concentration of CFU-S was 10 times greater than that in the blood, and the total number of CFU-S was over 100 times greater than that of normal animals. During the same period, in the bone marrow the number of CFU-S decreased to one-half of normal. Nevertheless, the CFU-S from MPSV-infected animals differentiated normally in the spleens of irradiated, normal recipient mice (except for some hyperplasia of the erythroid component of spleen colonies). The CFU-C content of the bone marrow, spleen, and blood paralleled the CFU-S content of these organs: The CFU-S and CFU-C populations changed almost synchronously after MPSV infection. In the terminal stage of the MPSV-induced disease, a variable proportion of the CFU-C population acquired the ability to differentiate in the absence of added colony-stimulating factor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262560

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

1.  The myeloproliferative sarcoma virus causes transformation or erythroid progenitor cells in vitro.

Authors:  W D Hankins; T A Kost; I B Pragnell
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

2.  Determinants of retrovirus gene expression in embryonal carcinoma cells.

Authors:  E Akgün; M Ziegler; M Grez
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.

Authors:  C Stocking; R Kollek; U Bergholz; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  SV7, a molecular clone of Moloney murine sarcoma virus 349, transforms vascular endothelial cells.

Authors:  P H Yuen; C M Matherne; L M Molinari-Storey
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

5.  Sequential study on spontaneous colony formation by bone marrow cells during butylnitrosourea-induced leukemogenesis in the rat.

Authors:  Y Takano; T Kitagawa; Y Urano
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector.

Authors:  J Friel; C Stocking; A Stacey; W Ostertag
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

7.  Retroviral mutants efficiently expressed in embryonal carcinoma cells.

Authors:  T Franz; F Hilberg; B Seliger; C Stocking; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in Balb/c mice.

Authors:  G Stoica; J Hoffman; P H Yuen
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

9.  Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants.

Authors:  R Kollek; C Stocking; F Smadja-Joffe; W Ostertag
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

10.  Action of temperature-sensitive mutants of myeloproliferative sarcoma virus suggests that fibroblast-transforming and hematopoietic transforming viral properties are related.

Authors:  W Ostertag; M Freshney; K Vehmeyer; C Jasmin; G Rutter
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.